急性B型主动脉夹层出院后90天再入院负担
基于美国全国再入院数据库2010至2014年6937例急性B型主动脉夹层非计划入院成人患者,分析90天非计划再入院情况。结果显示25.1%发生非计划再入院,单纯药物治疗、开放手术与TEVAR分别为23.6%、26.9%与28.7%(P < .001),再入院最常见病因为新发或复发性动脉瘤或夹层(24.8%)。
要点
- 急性B型主动脉夹层后90天非计划再入院率高达25.1%,三种初始治疗下均较高。
- 再入院最常见病因为新发或复发性动脉瘤或夹层,占24.8%。
- 非计划再入院期间死亡率为5.0%,平均再住院费用$22,572 ± $41,598。
核心结论
- 超过四分之一急性B型主动脉夹层患者在入院后90天内发生非计划再入院,绝对再入院率随初始治疗不同而异,但无论初始治疗如何均较高。
- 再入院最常见病因为主动脉疾病,尤其在单纯药物治疗者中更为突出。
- 需进一步研究降低这些高费用、高致病率再入院的潜在干预措施,包括多学科主动脉团队的作用。
研究设计与样本
- 回顾性队列分析,使用美国全国再入院数据库(Nationwide Readmissions Database)。
- 主要结局为非计划90天再入院,采用分层逻辑回归确定再入院预测因素。
- 研究人群为6937例因B型主动脉夹层非计划入院的患者。
主要发现
- 62.6%患者仅接受药物治疗,21.0%接受开放手术修复,16.4%接受TEVAR。
- 非计划90天再入院率为25.1%,单纯药物治疗为23.6%,开放修复为26.9%,TEVAR为28.7%(P < .001)。
- 另有4.7%患者为择期再入院。
- 非计划再入院最常见病因为新发或复发性动脉瘤或夹层(24.8%)。
- 非计划再入院者中5.2%接受主动脉手术;非计划再入院期间死亡率为5.0%,再住院平均费用为$22,572 ± $41,598。
关键数值与推荐
- 非计划90天再入院率:总体25.1%;单纯药物治疗23.6%;开放手术修复26.9%;TEVAR 28.7%;组间比较P < .001。
- 择期再入院比例:4.7%。
- 非计划再入院最常见病因:新发或复发性动脉瘤或夹层,占24.8%。
- 非计划再入院者接受主动脉手术比例:5.2%。
- 非计划再入院期间死亡率:5.0%;再住院平均费用:$22,572 ± $41,598。
临床怎么用
- 对急性B型主动脉夹层出院患者,应关注90天内非计划再入院风险,三种初始治疗后风险均较高。
- 再入院最常见病因为主动脉疾病,尤其单纯药物治疗者,出院后随访应重点监测主动脉病变进展。
- 可考虑多学科主动脉团队参与随访管理,以探索降低再入院风险的干预措施。
局限性
- 原文摘要未报告具体局限性内容。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Acute type B aortic dissection can be treated with medical management alone, open surgical repair, or thoracic endovascular aortic repair (TEVAR). The nationwide burden of readmissions after acute type B aortic dissection has not been comprehensively assessed. METHODS: We analyzed adults with a hospitalization due to acute type B aortic dissection between January 1, 2010, and December 31, 2014, in the Nationwide Readmissions Database. International Classification of Diseases, Ninth Revision, Clinical Modification codes were used to identify hospitalizations with a primary diagnosis code for thoracic or thoracoabdominal aortic dissection. The primary outcome was nonelective 90-day readmission. Predictors of readmission were determined using hierarchical logistic regression. RESULTS: The study population consisted of 6937 patients with unplanned admissions for type B aortic dissections from 2010 through 2014. Medical management alone was the treatment for 62.6% of patients, 21.0% had open surgical repair, and 16.4% underwent TEVAR. Nonelective 90-day readmission rate was 25.1% (23.6% with medical management alone, 26.9% with open repair, and 28.7% with TEVAR; P < .001). An additional 4.7% of patients were electively readmitted. The most common cause for nonelective readmission was new or recurrent arterial aneurysm or dissection (24.8%). Of those with unplanned readmissions, 5.2% underwent an aortic procedure. The mortality rate during nonelective readmission was 5.0%, and the mean cost of the rehospitalization was $22,572 ± $41,598. CONCLUSIONS: More than one in four patients have a nonelective readmission 90 days after hospitalization for acute type B aortic dissection. Absolute rates of readmission varied by initial treatment received but were high irrespective of the initial treatment. The most common cause of readmission was aortic disease, particularly among those treated with medication alone. Further research is required to determine potential interventions to decrease these costly and morbid readmissions, including the role of multidisciplinary aortic teams.
引用
- Carroll BJ, Schermerhorn M, Kennedy KF, et al. Readmissions after acute type B aortic dissection. J Vasc Surg. 2019. PMID: 31839347. doi:10.1016/j.jvs.2019.08.280
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。